All In MedTech

Device Trial Radar · NCT01783132

Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

Last checked: Nov 19, 2026Latest source record: Sep 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 142 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

142

Actual

Start

Dec 1, 2012

Primary completion

Apr 1, 2014

Study completion Apr 28, 2014

Sponsor

Lead sponsor
Orion Corporation, Orion PharmaNot on our public-company list
Sponsor type
Industry
Collaborators
Aerocrine AB
First posted
Feb 4, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the clinical outcome (effectiveness) of single inhaled corticosteroid (ICS) controller treatment guided by exhaled NO measurement made at home with usual care asthma management with regard to asthma control (primary outcome), asthma-related quality of life, lung function, airway inflammation, medication use, and asthma events. To understand changes in patient behaviour triggered by daily FENO measurement at home, for example treatment adherence and voluntary allergen exposure.

Conditions

  • Asthma

Interventions

  • NIOX MINODevice

    Active group (Budesonide) will be measuring exhaled NO at least 3 times/week at home to control their Asthma treatment via a algorithm schedule. The control group (Standard of care) will be measuring exhaled NO 4 times/year at study site.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Asthma symptoms in correlation to grade of inflammation in airwaysTime frame: Up to 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lungkliniken, Universitetssjukhuset i Uppsala

    Uppsala, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.